Delivery Order SPE2DB22D1106-SPE2DB25FFEM2
- Not listed
- The Defense Logistics Agency awarded a $1,837.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 0.5 mg/5 mL elixir (237 mL), with an ultimate completion date of August 11, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,619.29 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dexamethasone 10 mg/mL vials. This competitively awarded, firm fixed-price delivery order is set to conclude on August 13, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Dexamethasone 20 mg/5 mL vials with a ceiling value of $1,343.25. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Department of Defense's Medical Supply Chain issued a delivery order (Contract No. 4568944715) to AmerisourceBergen Drug Corp for the supply of Dexamethasone 30ML on July 31, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,784.46 and is scheduled for completion by August 27, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a $14,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562108791 DEXAMETHASONE 0.5 MG/5 ML LIQ 500ML. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance from September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,485 to Amerisourcebergen Drug Corporation for Dexamethasone 0.5 mg/5 ml elixir totaling 237 ml. Performance will occur in Conshohocken, Pennsylvania under a contract vehicle held by Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide 237 mL bottles of 0.5 mg/5 mL dexamethasone elixir. The $1,231.40 award has a completion date of February 5, 2024. Amerisourcebergen Drug Corp. is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEM2Delivery Order
The Defense Logistics Agency awarded a $5,681.22 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Dexamethasone 0.5 mg/5 ml elixir in a 237 ml quantity, with an ultimate completion date of August 21, 2025. This competitively awarded contract utilizes firm fixed-price pricing and does not include a set-aside designation. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. The dexamethasone delivery under this order fulfills ongoing pharmaceutical supply requirements for federal healthcare operations, consistent with AmerisourceBergen's role as a primary vendor within DLA's global pharmaceutical support network serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/20/25 |